Background and Purpose—The use of oral anticoagulant therapy for stroke prevention in atrial fibrillation has been transformed by the availability of the nonvitamin K antagonist oral anticoagulants...
CITATION STYLE
Proietti, M., Romanazzi, I., Romiti, G. F., Farcomeni, A., & Lip, G. Y. H. (2018). Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation. Stroke, 49(1), 98–106. https://doi.org/10.1161/strokeaha.117.018395
Mendeley helps you to discover research relevant for your work.